Table:
begin	end	state
1	15	cytoplasmic
16	33	transmembrane
34	52	non-cytoplasmic
53	73	transmembrane
74	84	cytoplasmic
85	104	transmembrane
105	109	non-cytoplasmic
110	131	transmembrane
132	143	cytoplasmic
144	167	transmembrane
168	182	non-cytoplasmic
183	204	transmembrane
205	264	cytoplasmic
265	288	transmembrane
289	303	non-cytoplasmic
304	325	transmembrane
326	332	cytoplasmic
333	355	transmembrane
356	369	non-cytoplasmic
370	395	transmembrane
396	406	cytoplasmic
407	430	transmembrane
431	435	non-cytoplasmic
436	454	transmembrane
455	479	cytoplasmic

Input:
>WP_058930749.1 NCBI__GCF_001484605.1:WP_058930749.1
MPTAKEQTTAKIPQRVIWLALAGAVGGFLFGFDSSVVNGAVDAIKDEFALSEAVTGFAVA
IALLGCAAGAFLAGKVADRYGRIPAMKLGALLFLVSAIGTGFAFGVWDLIFWRLVGGLGI
GLASVIAPAYISEISPRQVRGRLASLQQLAITTGIFAALLSDALFATTAGGADQAFWLGL
EAWRWMFLAAAVPAVVYGWIAYTLPESPRFLVFQGKEDEARKVFDSIAPSEDTDRHIREI
QDAIEEDKLSGQKGSLRGKTFGLQAVVWVGIVLSVLQQFVGINVIFYYSTTLWKAVGFQE
KDSLTISVATSITNILVTLVAIALVDRIGRRPILLAGSIGMAVSLGTMALAFSAAVGSGS
EISLPGAWGPVALVAANIFVVSFGASWGPLVWVLLGEIFPSRIRARALGLAAAAQWVANF
AITLSFPVMAAASLPLTYAMYALFAAASFFFVMFKVPETNGMSLEQAETLFVPKGSKKA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server